heart and vascular
play

Heart and Vascular Who should be screened? 40+ years old If you smoke /are around second-hand smoke If you are diabetic If you have a family history of heart disease, stroke, aneurysm If you are overweight If you have high

0 downloads 2 Views 400 KB Size Report
  1. Heart and Vascular Who should be screened? ▪ 40+ years old ▪ If you smoke /are around second-hand smoke ▪ If you are diabetic ▪ If you have a family history of heart disease, stroke, aneurysm ▪ If you are overweight ▪ If you have high blood pressure ▪ If you have had any previous heart conditions

  2. Cancer Who should be screened? While anyone can be at risk for Cancer below are some common risk factors • Age • Alcohol • Cancer causing substances • Chronic Inflammation • Diet • Family History • Hormones • Sunlight • Tobacco • Immunosuppression

  3. HEART & VASCULAR AND CANCER SCREENING PERFORMED VIA ULTRASOUND 25 MINUTES PAIN-FREE INTERACTIVE EASY IMMEDIATE FEEDBACK

  4. We’ve Got It Covered… Step 1 Employee Education Marketing Tools ▪ Pre-Screening Education ▪ Registration/Scheduling Step 2 ▪ Follow-up Online Scheduling Flexibility & Support Step 3 Abnormal Referrals Executive Summary

  5. Executive Summary Example

  6. My Story and Demo

Recommend Documents


what is peripheral vascular
What is Peripheral Vascular Disease?

10/10/2015 Peripheral Vascular Disease Ganesh Muthappan, MD, FACC

vascular surgery headline
Vascular Surgery Headline Surgical

Vascular Surgery Headline Surgical Treatments of Swedish Heart &

vascular institute
Vascular Institute Affiliate Network:

Gill Heart and Vascular Institute Affiliate Network: 2018 Update Gill Heart

pulmonary vascular changes in pulmonary vascular changes
Pulmonary Vascular Changes in

Pulmonary Vascular Changes in Pulmonary Vascular Changes in Heart Disease

disclosures
Disclosures Threatening Ischemia NONE

4/16/2016 Anatomic Staging for Chronic Limb Disclosures Threatening Ischemia

hypertension
Hypertension Ivan Anderson, MD

. Hypertension Ivan Anderson, MD Cardiologist Renown Institute for Heart

revolutionary monitoring technology for vascular health
Revolutionary Monitoring Technology

Revolutionary Monitoring Technology for Vascular Health SIMPLE | NON-INVASIVE

most important clinical trials
Most Important Clinical Trials of the

Most Important Clinical Trials of the Past Decade in Vascular Intervention

what are my treatment options for af
What Are My Treatment Options for AF?

What Are My Treatment Options for AF? Mikhael El-Chami, MD FACC, FHRS Emory

optimizing the performance of
Optimizing The Performance Of None

4/7/2017 Disclosure Optimizing The Performance Of None Your Vascular Lab

7 th vascular biomechanics society
7 th Vascular Biomechanics Society

7 th Vascular Biomechanics Society Does Arterial Stiffness Contribute to

ekg amp vital signs training
EKG & Vital Signs Training for

EKG & Vital Signs Training for Clinical Research Coordinators CCI Nursing

advanced registered nurse practitioner wound amp ostomy
Advanced Registered Nurse

Kimberly D. Thomas, DNP, ARNP, CWCN-AP, COCN Advanced Registered Nurse

poster presentation day 1 april 12 th 2019
Poster Presentation Day 1 (April 12 th

Poster Presentation Day 1 (April 12 th , 2019) Name Poster Title Code

emis group plc 2012 results presentation
EMIS Group plc 2012 results

Healthcare without boundaries EMIS Group plc 2012 results presentation Mike

therapeutics company
Therapeutics Company Cynata

A Next Generation Stem Cell Therapeutics Company Cynata Therapeutics Limited

nathalie tzourio mazoyer
Nathalie TZOURIO-MAZOYER Atomic Energy

Brain lateralization and the emergence of language Nathalie TZOURIO-MAZOYER

the shoulder
The Shoulder By: Jess Feinberg, Nick

The Shoulder By: Jess Feinberg, Nick Williams, Matt Drum & Eric Beer

belgium 27th 1 hta de grade 3 toujours risque gt eleve
BELGIUM 27th !!! 1) HTA DE GRADE 3 =

BELGIUM 27th !!! 1) HTA DE GRADE 3 = TOUJOURS RISQUE > ELEVE 4 3 2)

management of spinal deformities in ankylosing spondylitis
MANAGEMENT OF SPINAL DEFORMITIES IN

MANAGEMENT OF SPINAL DEFORMITIES IN ANKYLOSING SPONDYLITIS DR. RAJESH

tumor necrosis factor inhibitor tnfi utilization among
Tumor Necrosis Factor- Inhibitor (

Tumor Necrosis Factor- Inhibitor ( TNFi) utilization among women with live